Results 191 to 200 of about 8,707,734 (384)

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

NUTRITIVE PROPERTIES OF PROTEINS OF THE MAIZE KERNEL

, 1914
Thomas B. Osborne, Lafayette B. Mendel, Edna L. Ferry, Alfred J. Wakeman   +3 more
openalex   +1 more source

Some properties of the malic enzyme of pigeon liver. 2. Synthesis of malate from pyruvate [PDF]

, 1959
R. G. Stickland
openalex   +1 more source

Requirements for patentability [PDF]

, 2010
Korean Intellectual Property Office
core  

Externalities in wild pig damages on U.S. crop and livestock farms: The role of landowner actions and landscape heterogeneity. [PDF]

PLoS One
McKee SC, DeLay ND, Mooney DF, Shwiff SA.   +3 more
europepmc   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

THE PURIFICATION AND PROPERTIES OF LYSOZYME

, 1936
Karl Meyer, Richard J. Thompson, John W. Palmer, Devorah Khorazo   +3 more
openalex   +1 more source

STUDIES OF THE STAPHYLOCOAGULASE REACTION: NATURE AND PROPERTIES OF A PLASMA ACTIVATOR AND INHIBITOR [PDF]

, 1948
Melvin H. Kaplan, Wesley W. Spink
openalex   +1 more source

Quantum indeterminacy: a matter of degree? [PDF]

Eur J Philos Sci
Nørgaard M.
europepmc   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source